| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |